However, plasma GFAP levels are significantly higher in AD and dementia with Lewy bodies compared to other dementias [211, 222], suggesting that GFAP may be particularly useful in differentiating AD from frontotemporal dementia and Parkinson’s disease dementia. This evidence concerns the gene GFAP and Alzheimer disease.